Human amniotic fluid stem cell preconditioning improves their regenerative potential

Stem Cells and Development

Volumn 21, Issue 11, 2012, Pages 1911-1923

  Rota, Cinzia ^a   Imberti, Barbara ^a   Pozzobon, Michela ^b   Piccoli, Martina ^b   De Coppi, Paolo ^b,c   Atala, Anthony ^d   Gagliardini, Elena ^a   Xinaris, Christodoulos ^a   Benedetti, Valentina ^a   Fabricio, Aline S C ^e   Squarcina, Elisa ^f   Abbate, Mauro ^a   Benigni, Ariela ^a   Remuzzi, Giuseppe ^a,g   Morigi, Marina ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e Regional Center for Biomarkers ABO Foundation   (Italy)

^f VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^g OSPEDALI RIUNITI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; B7 ANTIGEN; BETA1 INTEGRIN; CD86 ANTIGEN; CHEMOKINE RECEPTOR CX3CR1; CHEMOKINE RECEPTOR CXCR4; CISPLATIN; ENDOGLIN; FIBROBLAST GROWTH FACTOR 2; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; HERMES ANTIGEN; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 6; KI 67 ANTIGEN; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN KINASE B; SCATTER FACTOR; STAGE SPECIFIC EMBRYO ANTIGEN 4; STEM CELL FACTOR RECEPTOR; STROMAL CELL DERIVED FACTOR 1; THY 1 ANTIGEN; VASCULOTROPIN;

ACUTE KIDNEY FAILURE; AMNIOTIC FLUID CELL; AMNIOTIC FLUID STEM CELL PRECONDITIONING; AMNIOTIC FLUID STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL HOMING; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL REGENERATION; CELL SURVIVAL; CELL VIABILITY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CONVALESCENCE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENGRAFTMENT; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY FUNCTION; KIDNEY INTERSTITIUM; KIDNEY TUBULE DAMAGE; MOUSE; NONHUMAN; POST TREATMENT SURVIVAL; PRIORITY JOURNAL; PROCEDURES CONCERNING CELLS; PROTEIN EXPRESSION; STEM CELL TRANSPLANTATION; WOUND HEALING;

ACUTE KIDNEY INJURY; AMNIOCENTESIS; AMNIOTIC FLUID; ANIMALS; APOPTOSIS; BLOOD UREA NITROGEN; CELL DIFFERENTIATION; CELL MOVEMENT; CELL SURVIVAL; CISPLATIN; CULTURE MEDIA, CONDITIONED; FEMALE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; MICE; MICE, INBRED NOD; MICE, SCID; REGENERATION; STEM CELL TRANSPLANTATION; STEM CELLS; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS;

ANIMALIA; MURINAE; MUS;

EID: 84863936271     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2011.0333     Document Type: Article

References (46)

1. Choi YH, T Saric, B Nasseri, S Huhn, S Van Linthout, R Hetzer, C Tschope and C Stamm. (2011). Cardiac cell therapies: the next generation. Cardiovasc Ther 29:2-16.
2. Shimada IS and JL Spees. (2011). Stem and progenitor cells for neurological repair: minor issues, major hurdles, and exciting opportunities for paracrine-based therapeutics. J Cell Biochem 112:374-380.
3. Morigi M, A Benigni, G Remuzzi and B Imberti. (2006). The regenerative potential of stem cells in acute renal failure. Cell Transplant 15 (Suppl. 1):S111-S117.
4. Bussolati B, C Tetta and G Camussi. (2008). Contribution of stem cells to kidney repair. Am J Nephrol 28:813-822.
5. Mazzinghi B, E Ronconi, E Lazzeri, C Sagrinati, L Ballerini, ML Angelotti, E Parente, R Mancina, GS Netti, et al. (2008). Essential but differential role for CXCR4 and CXCR7 in the therapeutic homing of human renal progenitor cells. J Exp Med 205:479-490. (Pubitemid 351281611)
6. Hopkins C, J Li, F Rae and MH Little. (2009). Stem cell options for kidney disease. J Pathol 217:265-281.
7. Cheng Z, L Ou, X Zhou, F Li, X Jia, Y Zhang, X Liu, Y Li, CA Ward, LG Melo and D Kong. (2008). Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol Ther 16:571-579. (Pubitemid 351314998)
8. Iwatani H and E Imai. (2010). Kidney repair using stem cells: myth or reality as a therapeutic option? J Nephrol 23:143-146
9. Herrera MB, B Bussolati, S Bruno, V Fonsato, GM Romanazzi and G Camussi. (2004). Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury. Int J Mol Med 14:1035-1041.
10. Morigi M, B Imberti, C Zoja, D Corna, S Tomasoni, M Abbate, D Rottoli, S Angioletti, A Benigni, et al. (2004). Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J Am Soc Nephrol 15:1794-1804. (Pubitemid 38822058)
11. Togel F, Z Hu, K Weiss, J Isaac, C Lange and C Westenfelder. (2005). Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol 289:F31-F42. (Pubitemid 40863570)
12. Bi B, R Schmitt, M Israilova, H Nishio and LG Cantley. (2007). Stromal cells protect against acute tubular injury via an endocrine effect. J Am Soc Nephrol 18:2486-2496. (Pubitemid 47378865)
13. Togel F, K Weiss, Y Yang, Z Hu, P Zhang and C Westenfelder. (2007). Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol 292:F1626-1635. (Pubitemid 46701891)
14. Morigi M, M Introna, B Imberti, D Corna, M Abbate, C Rota, D Rottoli, A Benigni, N Perico, et al. (2008). Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells 26:2075-2082.
15. Morigi M, C Rota, T Montemurro, E Montelatici, V Lo Cicero, B Imberti, M Abbate, C Zoja, P Cassis, et al. (2010). Lifesparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury. Stem Cells 28:513-522.
16. Poulsom R, SJ Forbes, K Hodivala-Dilke, E Ryan, S Wyles, S Navaratnarasah, R Jeffery, T Hunt, M Alison, et al. (2001). Bone marrow contributes to renal parenchymal turnover and regeneration. J Pathol 195:229-235. (Pubitemid 32899033)
17. Imberti B, M Morigi, S Tomasoni, C Rota, D Corna, L Longaretti, D Rottoli, F Valsecchi, A Benigni, et al. (2007). Insulin-like growth factor-1 sustains stem cell mediated renal repair. J Am Soc Nephrol 18:2921-2928. (Pubitemid 350058399)
18. Duffield JS, KM Park, LL Hsiao, VR Kelley, DT Scadden, T Ichimura and JV Bonventre. (2005). Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells. J Clin Invest 115:1743-1755. (Pubitemid 40979713)
19. Hyun I. (2010). The bioethics of stem cell research and therapy. J Clin Invest 120:71-75.
20. Odorico JS, DS Kaufman and JA Thomson. (2001). Multilineage differentiation from human embryonic stem cell lines. Stem Cells 19:193-204. (Pubitemid 32524540)
21. Takahashi K and S Yamanaka. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676. (Pubitemid 44233629)
22. De Coppi P, G Bartsch, Jr., MM Siddiqui, T Xu, CC Santos, L Perin, G Mostoslavsky, AC Serre, EY Snyder, et al. (2007). Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 25:100-106. (Pubitemid 46087908)
23. Cananzi M, A Atala and P De Coppi. (2009). Stem cells derived from amniotic fluid: new potentials in regenerative medicine. Reprod Biomed Online 18 Suppl 1:17-27.
24. Carraro G, L Perin, S Sedrakyan, S Giuliani, C Tiozzo, J Lee, G Turcatel, SP De Langhe, B Driscoll, et al. (2008). Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages. Stem Cells 26:2902-2911.
25. Ditadi A, P de Coppi, O Picone, L Gautreau, R Smati, E Six, D Bonhomme, S Ezine, R Frydman, M Cavazzana-Calvo and I Andre-Schmutz. (2009). Human and murine amniotic fluid c-Kit + Lin-cells display hematopoietic activity. Blood 113:3953-3960.
26. Tsuji H, S Miyoshi, Y Ikegami, N Hida, H Asada, I Togashi, J Suzuki, M Satake, H Nakamizo, et al. (2010). Xenografted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardiomyocytes. Circ Res 106:1613-1623.
27. Perin L, S Giuliani, D Jin, S Sedrakyan, G Carraro, R Habibian, D Warburton, A Atala and RE De Filippo. (2007). Renal differentiation of amniotic fluid stem cells. Cell Prolif 40:936-948. (Pubitemid 350139201)
28. Shi H, D Patschan, GP Dietz, M Bahr, M Plotkin and MS Goligorsky. (2008). Glial cell line-derived neurotrophic growth factor increases motility and survival of cultured mesenchymal stem cells and ameliorates acute kidney injury. Am J Physiol Renal Physiol 294:F229-F235.
29. Bonegio R and W Lieberthal. (2002). Role of apoptosis in the pathogenesis of acute renal failure. Curr Opin Nephrol Hypertens 11:301-308. (Pubitemid 34496778)
30. Datta SR, A Brunet and ME Greenberg. (1999). Cellular survival: a play in three Akts. Genes Dev 13:2905-2927.
31. Chang F, JT Lee, PM Navolanic, LS Steelman, JG Shelton, WL Blalock, RA Franklin and JA McCubrey. (2003). Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 17:590-603. (Pubitemid 36395654)
32. Herrera MB, B Bussolati, S Bruno, L Morando, G Mauriello-Romanazzi, F Sanavio, I Stamenkovic, L Biancone and G Camussi. (2007). Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney Int 72:430-441. (Pubitemid 47237610)
33. Shi M, J Li, L Liao, B Chen, B Li, L Chen, H Jia and RC Zhao. (2007). Regulation of CXCR4 expression in human mesenchymal stem cells by cytokine treatment: role in homing efficiency in NOD/SCID mice. Haematologica 92:897-904. (Pubitemid 350144236)
34. Ji JF, BP He, ST Dheen and SS Tay. (2004). Interactions of chemokines and chemokine receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. Stem Cells 22:415-427. (Pubitemid 38736625)
35. Perin L, S Sedrakyan, S Giuliani, S Da Sacco, G Carraro, L Shiri, KV Lemley, M Rosol, S Wu, et al. (2010). Protective effect of human amniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis. PLoS One 5:e9357.
36. Hauser PV, R De Fazio, S Bruno, S Sdei, C Grange, B Bussolati, C Benedetto and G Camussi. (2010). Stem cells derived from human amniotic fluid contribute to acute kidney injury recovery. Am J Pathol 177:2011-2021.
37. Waxman AB and N Kolliputi. (2009). IL-6 protects against hyperoxia-induced mitochondrial damage via Bcl-2-induced Bak interactions with mitofusins. Am J Respir Cell Mol Biol 41:385-396.
38. Neufeld G, T Cohen, S Gengrinovitch and Z Poltorak. (1999). Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13:9-22. (Pubitemid 29038270)
39. Kuwana H, Y Terada, T Kobayashi, T Okado, JM Penninger, J Irie-Sasaki, T Sasaki and S Sasaki. (2008). The phosphoinositide-3 kinase gamma-Akt pathway mediates renal tubular injury in cisplatin nephrotoxicity. Kidney Int 73: 430-445. (Pubitemid 351186288)
40. Hagiwara M, B Shen, L Chao and J Chao. (2008). Kallikreinmodified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation. Hum Gene Ther 19:807-819.
41. Mangi AA, N Noiseux, D Kong, H He, M Rezvani, JS Ingwall and VJ Dzau. (2003). Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 9:1195-1201. (Pubitemid 37173705)
42. Mias C, E Trouche, MH Seguelas, F Calcagno, F Dignat-George, F Sabatier, MD Piercecchi-Marti, L Daniel, P Bianchi, et al. (2008). Ex vivo pretreatment with melatonin improves survival, proangiogenic/mitogenic activity, and efficiency of mesenchymal stem cells injected into ischemic kidney. Stem Cells 26:1749-1757.
43. Schmidt A, D Ladage, T Schinkothe, U Klausmann, C Ulrichs, FJ Klinz, K Brixius, S Arnhold, B Desai, et al. (2006). Basic fibroblast growth factor controls migration in human mesenchymal stem cells. Stem Cells 24:1750-1758. (Pubitemid 44474188)
44. Hung SC, RR Pochampally, SC Hsu, C Sanchez, SC Chen, J Spees and DJ Prockop. (2007). Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo. PLoS One 2:e416.
45. Costantini F and R Shakya. (2006). GDNF/Ret signaling and the development of the kidney. Bioessays 28:117-127.
46. Yokoo T, T Ohashi, JS Shen, K Sakurai, Y Miyazaki, Y Utsunomiya, M Takahashi, Y Terada, Y Eto, T Kawamura, N Osumi and T Hosoya. (2005). Human mesenchymal stem cells in rodent whole-embryo culture are reprogrammed to contribute to kidney tissues. Proc Natl Acad Sci U S A 102:3296-3300. (Pubitemid 40328039)